RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Laboratorios Farmaceuticos ROVI Stock

Laboratorios Farmaceuticos ROVI Dividend 2024

Laboratorios Farmaceuticos ROVI Dividend

1.29 EUR

Laboratorios Farmaceuticos ROVI Dividend yield

1.74 %

Ticker

ROVI.MC

ISIN

ES0157261019

WKN

A0M0GQ

How much dividend does Laboratorios Farmaceuticos ROVI 2024 pay?

According to the latest status from October 2024, Laboratorios Farmaceuticos ROVI paid a total of 1.29 EUR per share in dividends within the last 12 months. With the current Laboratorios Farmaceuticos ROVI price of 74.2 EUR, this corresponds to a dividend yield of 1.74 %. A dividend is paid 1 times per year.

1.74 % Dividend Yield=
1.29 EUR Dividend
74.2 EUR Stock Price

Historical Laboratorios Farmaceuticos ROVI Dividends

A dividend is paid 1 times per year. Last year, the payout months were and August.

PaydateDividend
8/8/20241.1
8/3/20231.29
8/5/20220.96
8/5/20210.38
12/17/20200.18
8/2/20190.08
8/3/20180.12
8/3/20170.18
7/30/20160.14
8/2/20150.17
8/3/20140.16
8/3/20130.14
8/4/20120.13
8/6/20110.17
8/6/20100.14
8/8/20090.09
10/17/20080.08
1

Laboratorios Farmaceuticos ROVI dividend history and estimates

In 2023, Laboratorios Farmaceuticos ROVI paid a dividend amounting to 1.29 EUR. Dividend means that Laboratorios Farmaceuticos ROVI distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Laboratorios Farmaceuticos ROVI provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Laboratorios Farmaceuticos ROVI’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Laboratorios Farmaceuticos ROVI's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Laboratorios Farmaceuticos ROVI Dividend History

DateLaboratorios Farmaceuticos ROVI Dividend
2028e1.69 undefined
2027e1.69 undefined
2026e1.69 undefined
2025e1.69 undefined
2024e1.69 undefined
20231.29 undefined
20220.96 undefined
20210.38 undefined
20200.18 undefined
20190.08 undefined
20180.12 undefined
20170.18 undefined
20160.14 undefined
20150.17 undefined
20140.16 undefined
20130.14 undefined
20120.13 undefined
20110.17 undefined
20100.14 undefined
20090.09 undefined
20080.08 undefined

Is the Laboratorios Farmaceuticos ROVI Dividend Safe?

Laboratorios Farmaceuticos ROVI has been increasing the dividend for 4 years.

Over the past 10 years, Laboratorios Farmaceuticos ROVI has increased it by an annual 25.211 %.

Over a five-year period, the distribution increased by 60.706%.

Analysts expect a Dividend Increase of 14.454% for the current fiscal year.

Laboratorios Farmaceuticos ROVI dividend payout ratio

In 2023, Laboratorios Farmaceuticos ROVI had a payout ratio of 18.42%. The payout ratio indicates the percentage of the company's profits that Laboratorios Farmaceuticos ROVI distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Laboratorios Farmaceuticos ROVI represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Laboratorios Farmaceuticos ROVI could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Laboratorios Farmaceuticos ROVI's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Laboratorios Farmaceuticos ROVI Payout Ratio History

DateLaboratorios Farmaceuticos ROVI Payout ratio
2028e20.23 %
2027e19.99 %
2026e19.6 %
2025e21.09 %
2024e19.27 %
202318.42 %
202225.59 %
202113.8 %
202015.88 %
201911.21 %
201834.55 %
201752.29 %
201626.12 %
201542.26 %
201433.35 %
201329.7 %
201232.54 %
201147.8 %
201028.78 %
200921.1 %
200816.66 %
200718.42 %
200618.42 %
200518.42 %
200418.42 %

Dividend Details

Understanding Laboratorios Farmaceuticos ROVI's Dividend Distributions

Laboratorios Farmaceuticos ROVI’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Laboratorios Farmaceuticos ROVI's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Laboratorios Farmaceuticos ROVI's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Laboratorios Farmaceuticos ROVI’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Laboratorios Farmaceuticos ROVI Aktienanalyse

What does Laboratorios Farmaceuticos ROVI do?

Laboratorios Farmaceuticos ROVI SA is a Spanish pharmaceutical company that was founded in 1946 by Salvador and Ignacio Ruiz-Salmones. The company is headquartered in Madrid and employs over 1,000 employees. ROVI manufactures a variety of pharmaceutical products and offers services in various areas. The company specializes in the development and manufacturing of specialty preparations in the fields of oncology, hematology, endocrinology, and gastroenterology. The company operates in three business areas: specialty pharmaceuticals, contrast agents, and active ingredients for the industry. The specialty pharmaceuticals business area includes medications for various applications, such as the treatment of cancer, blood disorders, endocrine disorders, gastroenterological disorders, and central nervous system disorders. The contrast agents division produces products for radiology and diagnostics. The products are used in various medical fields, from cardiology to gastroenterology. In the active ingredients for the industry business area, ROVI manufactures active ingredients for other pharmaceutical companies. ROVI specializes in the production of specialty products and relies on collaborations with other companies. The company has strategic partnerships with many companies such as GlaxoSmithKline, Pfizer, Sanofi-Aventis, and Zeltia. This also includes some research collaborations to develop and market products together. The company is also dedicated to the development of biosimilars, which allow for the offering of biologic drugs at a lower price. Biosimilars are copies of biopharmaceuticals that are usually very expensive due to the complex manufacturing process and high development costs. ROVI is also a major producer of vaccines that are distributed worldwide. ROVI has followed a solid growth trajectory in recent years. The company has been able to consistently increase its revenue and profit and is now a major player in the pharmaceutical industry. The company also operates a strong research and development department that constantly develops new products and technologies to improve patient care. In summary, Laboratorios Farmaceuticos ROVI SA is a leading pharmaceutical company specializing in the manufacturing of specialty products. With its subsidiaries in Europe and the USA, ROVI has an international presence and has made a name for itself through its expertise in the development and manufacturing of innovative pharmaceutical products. Laboratorios Farmaceuticos ROVI is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Laboratorios Farmaceuticos ROVI stock

How much dividend does Laboratorios Farmaceuticos ROVI pay?

Over the past 12 months, Laboratorios Farmaceuticos ROVI paid a dividend of 1.29 EUR . This corresponds to a dividend yield of about 1.74 %. For the coming 12 months, Laboratorios Farmaceuticos ROVI is expected to pay a dividend of 1.69 EUR.

What is the dividend yield of Laboratorios Farmaceuticos ROVI?

The current dividend yield of Laboratorios Farmaceuticos ROVI is 1.74 %.

When does Laboratorios Farmaceuticos ROVI pay dividends?

Laboratorios Farmaceuticos ROVI pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of Laboratorios Farmaceuticos ROVI?

Laboratorios Farmaceuticos ROVI paid dividends every year for the past 21 years.

What is the dividend of Laboratorios Farmaceuticos ROVI?

For the upcoming 12 months, dividends amounting to 1.69 EUR are expected. This corresponds to a dividend yield of 2.27 %.

In which sector is Laboratorios Farmaceuticos ROVI located?

Laboratorios Farmaceuticos ROVI is assigned to the 'Health' sector.

Wann musste ich die Aktien von Laboratorios Farmaceuticos ROVI kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Laboratorios Farmaceuticos ROVI from 7/10/2024 amounting to 1.104 EUR, you needed to have the stock in your portfolio before the ex-date on 7/8/2024.

When did Laboratorios Farmaceuticos ROVI pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of Laboratorios Farmaceuticos ROVI in the year 2023?

In the year 2023, Laboratorios Farmaceuticos ROVI distributed 0.956 EUR as dividends.

In which currency does Laboratorios Farmaceuticos ROVI pay out the dividend?

The dividends of Laboratorios Farmaceuticos ROVI are distributed in EUR.

Andere Kennzahlen von Laboratorios Farmaceuticos ROVI

Our stock analysis for Laboratorios Farmaceuticos ROVI Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Laboratorios Farmaceuticos ROVI Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.